Showing results (1911-1920 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|March 3, 2015
Cognitive function in patients with diabetes mellitus: guidance for daily carePaula S Koekkoek, L Jaap Kappelle, Esther van den Berg, et al.
The Lancet. Neurology|March 3, 2015
End-of-life management in patients with amyotrophic lateral sclerosisSheelah Connolly, Miriam Galvin, Orla Hardiman
The Lancet. Neurology|June 17, 2014
Malformations of cortical development: clinical features and genetic causesRenzo Guerrini, William B Dobyns
The Lancet. Neurology|March 31, 2015
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
The Lancet. Neurology|March 21, 2015
Neuroinflammation in Alzheimer's diseaseMichael T Heneka, Monica J Carson, Joseph El Khoury, et al.
The Lancet. Neurology|July 24, 2020
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial
The Lancet. Neurology|July 24, 2020
Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial
The Lancet. Neurology|January 28, 2014
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trialChristian Confavreux, Paul O'Connor, Giancarlo Comi, et al.
The Lancet. Neurology|May 20, 2014
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trialPeter J Kirkpatrick, Carole L Turner, Christopher Smith, et al.
The Lancet. Neurology|November 6, 2012
Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional studyPauline Maillard, Sudha Seshadri, Alexa Beiser, et al.
Pageof 200